Benzimidazoles and pharmaceutical compositions containing them
US5565469A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 13, 1995 |
| Grant date | Oct 15, 1996 |
| Priority date | — |
| Expiry date | Mar 13, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Angiotensin-II inhibiting benzimidazoles, useful for the treatment of hypertension. Exemplary compounds are: PA0 (a) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-(1,3-thiazolidin-2,4-dione-5-methylidinyl)-biphenyl, PA0 (b) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-sulpho-biphenyl, PA0 (c) 4'-[(2-ethyl-4-methyl-6-(5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-yl)-be nzimidazol-1-yl)-methyl]-2-sulpho-biphenyl, PA0 (d) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-trifluoroacetylamino-biphenyl, PA0 (e) 4'-[(2-ethyl-4-methyl-6-(5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-yl)-be nzimidazol-1-yl)-methyl]-2-trifluoroacetylamino-biphenyl, PA0 (f) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-(4-methoxy-benzylaminocarbonylaminosulphonyl)-biphenyl, PA0 (g) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-(cyclohexylamino-carbonylaminosulphonyl)-biphenyl, PA0 (h) 4'-[(2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)- methyl]-2-(benzoylamino-sulphonyl)-biphenyl, PA0 (i) 4'-[(2-ethyl-4…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.